|
September 30,
|
December 31,
|
|||||||
|
2025
|
2024
|
|||||||
|
$ millions
|
||||||||
|
Current assets
|
||||||||
|
Cash and cash equivalents
|
1,149
|
1,016
|
||||||
|
Trade receivables
|
127
|
80
|
||||||
|
Short-term derivative instruments
|
5
|
-
|
||||||
|
Other investments
|
112
|
143
|
||||||
|
Other current assets
|
33
|
24
|
||||||
|
Total current assets
|
1,426
|
1,263
|
||||||
|
Non-current assets
|
||||||||
|
Investment in OPC’s associated companies
|
1,624
|
1,459
|
||||||
|
Long-term restricted cash
|
16
|
16
|
||||||
|
Long-term derivative instruments
|
13
|
28
|
||||||
|
Deferred taxes, net
|
3
|
3
|
||||||
|
Property, plant and equipment, net
|
1,287
|
1,156
|
||||||
|
Intangible assets, net
|
80
|
72
|
||||||
|
Long-term prepaid expenses and other non-current assets
|
45
|
41
|
||||||
|
Right-of-use assets, net
|
194
|
175
|
||||||
|
Total non-current assets
|
3,262
|
2,950
|
||||||
|
Total assets
|
4,688
|
4,213
|
||||||
|
Current liabilities
|
||||||||
|
Current maturities of loans from banks and others
|
100
|
85
|
||||||
|
Trade and other payables
|
203
|
94
|
||||||
|
Current maturities of lease liabilities
|
3
|
4
|
||||||
|
Total current liabilities
|
306
|
183
|
||||||
|
Non-current liabilities
|
||||||||
|
Long-term loans from banks and others
|
911
|
727
|
||||||
|
Debentures
|
353
|
456
|
||||||
|
Deferred taxes, net
|
165
|
148
|
||||||
|
Other non-current liabilities
|
7
|
31
|
||||||
|
Long-term lease liabilities
|
8
|
9
|
||||||
|
Total non-current liabilities
|
1,444
|
1,371
|
||||||
|
Total liabilities
|
1,750
|
1,554
|
||||||
|
Equity
|
||||||||
|
Share capital
|
50
|
50
|
||||||
|
Translation reserve
|
24
|
3
|
||||||
|
Capital reserve
|
58
|
64
|
||||||
|
Accumulated profit
|
1,365
|
1,491
|
||||||
|
Equity attributable to owners of the Company
|
1,497
|
1,608
|
||||||
|
Non-controlling interests
|
1,441
|
1,051
|
||||||
|
Total equity
|
2,938
|
2,659
|
||||||
|
Total liabilities and equity
|
4,688
|
4,213
|
||||||
|
For the nine months
ended September 30,
|
For the three months
ended September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
$ millions
|
$ millions
|
|||||||||||||||
|
Revenue
|
644
|
592
|
265
|
237
|
||||||||||||
|
Cost of sales and services (excluding depreciation and amortization)
|
(468
|
)
|
(403
|
)
|
(178
|
)
|
(157
|
)
|
||||||||
|
Depreciation and amortization
|
(51
|
)
|
(66
|
)
|
(18
|
)
|
(24
|
)
|
||||||||
|
Gross profit
|
125
|
123
|
69
|
56
|
||||||||||||
|
Selling, general and administrative expenses
|
(93
|
)
|
(67
|
)
|
(45
|
)
|
(25
|
)
|
||||||||
|
Other income/(expenses), net
|
9
|
(3
|
)
|
10
|
6
|
|||||||||||
|
Operating profit
|
41
|
53
|
34
|
37
|
||||||||||||
|
Financing expenses
|
(72
|
)
|
(104
|
)
|
(27
|
)
|
(52
|
)
|
||||||||
|
Financing income
|
36
|
38
|
14
|
18
|
||||||||||||
|
Financing expenses, net
|
(36
|
)
|
(66
|
)
|
(13
|
)
|
(34
|
)
|
||||||||
|
Gains related to ZIM
|
-
|
111
|
-
|
-
|
||||||||||||
|
Dividend income
|
-
|
6
|
-
|
-
|
||||||||||||
|
Share in profit of associated companies, net
|
||||||||||||||||
|
- ZIM
|
-
|
40
|
-
|
40
|
||||||||||||
|
- OPC’s associated companies
|
120
|
41
|
61
|
17
|
||||||||||||
|
Profit before income taxes
|
125
|
185
|
82
|
60
|
||||||||||||
|
Income tax expense
|
(25
|
)
|
(14
|
)
|
(15
|
)
|
(6
|
)
|
||||||||
|
Profit for the year
|
100
|
171
|
67
|
54
|
||||||||||||
|
Attributable to:
|
||||||||||||||||
|
Kenon’s shareholders
|
41
|
163
|
25
|
43
|
||||||||||||
|
Non-controlling interests
|
59
|
8
|
42
|
11
|
||||||||||||
|
Profit for the period
|
100
|
171
|
67
|
54
|
||||||||||||
|
Basic/diluted profit per share attributable to Kenon’s shareholders (in dollars):
|
||||||||||||||||
|
Basic/diluted profit per share
|
0.77
|
3.09
|
0.45
|
0.81
|
||||||||||||
|
For the nine months
ended September 30,
|
||||||||
|
2025
|
2024
|
|||||||
|
$ millions
|
||||||||
|
Cash flows from operating activities
|
||||||||
|
Profit for the period
|
100
|
171
|
||||||
|
Adjustments:
|
||||||||
|
Depreciation and amortization
|
55
|
69
|
||||||
|
Diesel fuel consumption
|
6
|
3
|
||||||
|
Financing expenses, net
|
36
|
66
|
||||||
|
Gains related to ZIM
|
-
|
(111
|
)
|
|||||
|
Share in profit of associated companies, net
|
(120
|
)
|
(81
|
)
|
||||
|
Share-based payments
|
35
|
7
|
||||||
|
Other (income)/expenses, net
|
(9
|
)
|
8
|
|||||
|
Income tax expense
|
25
|
14
|
||||||
|
128
|
146
|
|||||||
|
Change in trade and other receivables
|
(48
|
)
|
(48
|
)
|
||||
|
Change in trade and other payables
|
44
|
41
|
||||||
|
Cash generated from operating activities
|
124
|
139
|
||||||
|
Income tax paid
|
(2
|
)
|
(1
|
)
|
||||
|
Dividends received from associate companies, net
|
||||||||
|
- ZIM
|
-
|
20
|
||||||
|
- OPC’s associated companies
|
59
|
55
|
||||||
|
Net cash provided by operating activities
|
181
|
213
|
||||||
|
For the nine months
ended September 30,
|
||||||||
|
2025
|
2024
|
|||||||
|
$ millions
|
||||||||
|
Cash flows from investing activities
|
||||||||
|
Short-term deposits and restricted cash, net
|
-
|
(2
|
)
|
|||||
|
Short-term collaterals deposits, net
|
-
|
3
|
||||||
|
Investment in long-term deposit, net
|
2
|
1
|
||||||
|
Investment in associated companies, less cash acquired
|
(135
|
)
|
(10
|
)
|
||||
|
Acquisition of property, plant and equipment
|
(67
|
)
|
(325
|
)
|
||||
|
Proceed from sale of interest in ZIM
|
-
|
111
|
||||||
|
Proceed from sale of subsidiary
|
-
|
2
|
||||||
|
Proceed from distribution from associated company
|
1
|
26
|
||||||
|
Proceeds from other investments
|
36
|
68
|
||||||
|
Interest received
|
30
|
20
|
||||||
|
Proceeds from transactions in derivatives, net
|
3
|
1
|
||||||
|
Net cash used in investing activities
|
(130
|
)
|
(105
|
)
|
||||
|
Cash flows from financing activities
|
||||||||
|
Repayment of long-term loans, debentures and lease liabilities
|
(192
|
)
|
(545
|
)
|
||||
|
Repayment of short-term loans
|
3
|
(53
|
)
|
|||||
|
Investments of non-controlling interests in subsidiary
|
10
|
-
|
||||||
|
Tax equity investment
|
-
|
41
|
||||||
|
Proceeds from issuance of share capital by a subsidiary to non-controlling interests, net of issuance expenses
|
407
|
108
|
||||||
|
Proceeds from issuance of debentures, less issuance expenses
|
52
|
|||||||
|
Proceeds from long-term loans
|
146
|
460
|
||||||
|
Proceeds from derivative financial instruments, net
|
5
|
3
|
||||||
|
Dividend paid
|
(261
|
)
|
(201
|
)
|
||||
|
Repurchased of own shares
|
(10
|
)
|
(2
|
)
|
||||
|
Interest paid
|
(43
|
)
|
(53
|
)
|
||||
|
Net cash provided/(used in) financing activities
|
65
|
(190
|
)
|
|||||
|
Increase/(decrease) in cash and cash equivalents
|
116
|
(82
|
)
|
|||||
|
Cash and cash equivalents at beginning of the year
|
1,016
|
697
|
||||||
|
Effect of exchange rate fluctuations on balances of cash and cash equivalents
|
17
|
-
|
||||||
|
Cash and cash equivalents at end of the period
|
1,149
|
615
|
||||||
|
For the nine months
ended September 30, 2025
|
||||||||||||||||
|
OPC Israel
|
CPV Group
|
Other
|
Consolidated Results
|
|||||||||||||
|
$ millions
|
||||||||||||||||
|
Revenue
|
511
|
133
|
-
|
644
|
||||||||||||
|
Depreciation and amortization
|
(55
|
)
|
-
|
-
|
(55
|
)
|
||||||||||
|
Financing income
|
8
|
7
|
21
|
36
|
||||||||||||
|
Financing expenses
|
(26
|
)
|
(36
|
)
|
(10
|
)
|
(72
|
)
|
||||||||
|
Share in profit of associated companies
|
-
|
120
|
-
|
120
|
||||||||||||
|
Profit before taxes
|
83
|
35
|
7
|
125
|
||||||||||||
|
Income tax (expense)/benefits
|
(22
|
)
|
1
|
(4
|
)
|
(25
|
)
|
|||||||||
|
Profit for the period
|
61
|
36
|
3
|
100
|
||||||||||||
|
|
For the nine months
ended September 30, 2024
|
|||||||||||||||||||
|
OPC Israel
|
CPV Group
|
ZIM
|
Other
|
Consolidated Results
|
||||||||||||||||
|
$ millions
|
||||||||||||||||||||
|
Revenue
|
496
|
96
|
-
|
-
|
592
|
|||||||||||||||
|
Depreciation and amortization
|
(52
|
)
|
(20
|
)
|
-
|
-
|
(72
|
)
|
||||||||||||
|
Financing income
|
17
|
3
|
-
|
18
|
38
|
|||||||||||||||
|
Financing expenses
|
(63
|
)
|
(24
|
)
|
-
|
(17
|
)
|
(104
|
)
|
|||||||||||
|
Gains related to ZIM
|
-
|
-
|
111
|
-
|
111
|
|||||||||||||||
|
Share in profit of associated companies
|
-
|
41
|
40
|
-
|
81
|
|||||||||||||||
|
Profit/(loss) before taxes
|
34
|
(1
|
)
|
151
|
1
|
185
|
||||||||||||||
|
Income tax (expense)/benefits
|
(15
|
)
|
2
|
-
|
(1
|
)
|
(14
|
)
|
||||||||||||
|
(Loss)/profit for the period
|
19
|
1
|
151
|
-
|
171
|
|||||||||||||||
|
For the three months
ended September 30, 2025
|
||||||||||||||||
|
OPC Israel
|
CPV Group
|
Other
|
Consolidated Results
|
|||||||||||||
|
$ millions
|
||||||||||||||||
|
Revenue
|
212
|
53
|
-
|
265
|
||||||||||||
|
Depreciation and amortization
|
(19
|
)
|
-
|
-
|
(19
|
)
|
||||||||||
|
Financing income
|
6
|
3
|
5
|
14
|
||||||||||||
|
Financing expenses
|
(7
|
)
|
(15
|
)
|
(5
|
)
|
(27
|
)
|
||||||||
|
Share in profit of associated companies
|
-
|
61
|
-
|
61
|
||||||||||||
|
Profit/(loss) before taxes
|
65
|
18
|
(1
|
)
|
82
|
|||||||||||
|
Income tax expense
|
(13
|
)
|
(1
|
)
|
(1
|
)
|
(15
|
)
|
||||||||
|
Profit/(loss) for the period
|
52
|
17
|
(2
|
)
|
67
|
|||||||||||
|
|
For the three months
ended September 30, 2024
|
|||||||||||||||||||
|
OPC Israel
|
CPV Group
|
ZIM
|
Other
|
Consolidated Results
|
||||||||||||||||
|
$ millions
|
||||||||||||||||||||
|
Revenue
|
205
|
32
|
-
|
-
|
237
|
|||||||||||||||
|
Depreciation and amortization
|
(19
|
)
|
(7
|
)
|
-
|
-
|
26
|
|||||||||||||
|
Financing income
|
12
|
1
|
-
|
5
|
18
|
|||||||||||||||
|
Financing expenses
|
(31
|
)
|
(9
|
)
|
-
|
(12
|
)
|
(52
|
)
|
|||||||||||
|
Share in profit of associated companies
|
-
|
17
|
40
|
-
|
57
|
|||||||||||||||
|
Profit/(loss) before taxes
|
31
|
(2
|
)
|
40
|
(9
|
)
|
60
|
|||||||||||||
|
Income tax (expense)/benefits
|
(8
|
)
|
2
|
-
|
-
|
(6
|
)
|
|||||||||||||
|
Profit/(loss) for the period
|
23
|
-
|
40
|
(9
|
)
|
54
|
||||||||||||||
|
For the nine months
ended September 30,
|
For the three months
ended September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
$ millions
|
$ millions
|
|||||||||||||||
|
Revenue
|
644
|
592
|
265
|
237
|
||||||||||||
|
Cost of sales (excluding depreciation and amortization)
|
(468
|
)
|
(403
|
)
|
(178
|
)
|
(157
|
)
|
||||||||
|
Depreciation and amortization
|
(51
|
)
|
(66
|
)
|
(18
|
)
|
(24
|
)
|
||||||||
|
Gross profit
|
125
|
123
|
69
|
56
|
||||||||||||
|
Selling, general and administrative expenses
|
(85
|
)
|
(62
|
)
|
(44
|
)
|
(22
|
)
|
||||||||
|
Other income/(expenses), net
|
5
|
(2
|
)
|
10
|
5
|
|||||||||||
|
Operating profit
|
45
|
59
|
35
|
39
|
||||||||||||
|
Financing expenses
|
(62
|
)
|
(87
|
)
|
(22
|
)
|
(40
|
)
|
||||||||
|
Financing income
|
15
|
20
|
9
|
13
|
||||||||||||
|
Financing expenses, net
|
(47
|
)
|
(67
|
)
|
(13
|
)
|
(27
|
)
|
||||||||
|
Share in profit of associated companies, net
|
120
|
41
|
61
|
17
|
||||||||||||
|
Profit before income taxes
|
118
|
33
|
83
|
29
|
||||||||||||
|
Income tax expense
|
(21
|
)
|
(13
|
)
|
(14
|
)
|
(6
|
)
|
||||||||
|
Profit for the period
|
97
|
20
|
69
|
23
|
||||||||||||
|
Attributable to:
|
||||||||||||||||
|
Equity holders of the company
|
74
|
23
|
54
|
22
|
||||||||||||
|
Non-controlling interest
|
23
|
(3
|
)
|
15
|
1
|
|||||||||||
|
Profit for the period
|
97
|
20
|
69
|
23
|
||||||||||||
|
For the nine months
ended September 30, |
For the three months
ended September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
$ millions
|
$ millions
|
|||||||||||||||
|
Cash flows provided by operating activities
|
190
|
201
|
112
|
112
|
||||||||||||
|
Cash flows used in investing activities
|
(188
|
)
|
(297
|
)
|
(48
|
)
|
(158
|
)
|
||||||||
|
Cash flows provided by financing activities
|
413
|
128
|
163
|
162
|
||||||||||||
|
Increase/(decrease) in cash and cash equivalents
|
415
|
32
|
227
|
116
|
||||||||||||
|
Cash and cash equivalents at beginning of the year
|
264
|
278
|
264
|
278
|
||||||||||||
|
Effect of exchange rate fluctuations on balances of cash and cash equivalents
|
17
|
-
|
(1
|
)
|
(84
|
)
|
||||||||||
|
Cash and cash equivalents at end of the period
|
696
|
310
|
696
|
310
|
||||||||||||
|
|
As at
|
|||||||
|
|
September 30, 2025
|
December 31, 2024
|
||||||
|
|
$ millions
|
|||||||
|
Total financial liabilities1
|
1,364
|
1,267
|
||||||
|
Total monetary assets2
|
713
|
280
|
||||||
|
Investment in associated companies
|
1,624
|
1,459
|
||||||
|
Total equity attributable to the owners
|
1,898
|
1,303
|
||||||
|
Total assets
|
4,124
|
3,309
|
||||||
|
1.
|
Including loans from banks and others and debentures
|
|
2.
|
Including cash and cash equivalents, term deposits and restricted cash
|
|
For the three months
ended September 30,
|
||||||||
|
|
2025
|
2024
|
||||||
|
|
$ millions
|
|||||||
|
Profit for the period
|
69
|
23
|
||||||
|
Depreciation and amortization
|
19
|
26
|
||||||
|
Financing expenses, net
|
13
|
27
|
||||||
|
Income tax expense
|
14
|
6
|
||||||
|
EBITDA
|
115
|
82
|
||||||
|
Share of depreciation and amortization and financing expenses included within share of profit of associated companies, net and income tax expenses (if any) of associated
companies
|
51
|
27
|
||||||
|
Expenses, not in the ordinary course of business and/or of a non-recurring nature
|
(10
|
)
|
(1
|
)
|
||||
|
Adjusted EBITDA including proportionate share of associated companies
|
156
|
108
|
||||||